Advertisement
Canadian Journal of Ophthalmology
Canadian Ophthalmological Society
Advanced searchSave search
Research Article| Volume 44, SUPPLEMENT 1, S55-S93, June 2009

Guide factuel de pratique clinique de la Société canadienne d’ophtalmologie pour la gestion du glaucome chez l’adulte

  • Comité d’expertise du Guide factuel de pratique clinique de la Société canadienne d’ophtalmologie pour la gestion du glaucome chez l’adulte
    Author Footnotes
    1 Comité d’expertise du Guide factuel de pratique clinique de la Société canadienne d’ophtalmologie pour la gestion du glaucome chez l’adulte: Paul E. Rafuse, MD PhD FRCSC (président), Halifax, N.-É; Yvonne M. Buys, MD FRCSC, Toronto, Ont.; Karim F. Damji, MD MBA FRCSC, Edmonton, Alb.; Paul Harasymowycz, MD FRCSC, Montréal, Qc.; Caroline Lajoie, MD, MSc, FRCSC, DABO, Québec, Qc.; Frederick S. Mikelberg MD FRCSC, Vancouver, C.-B; Paul H. Murphy, MD FRCSC, Saskatoon, Sask.; Marcelo Nicolela, MD FRCSC, Halifax, N.-É; David P. Tingey, MD FRCSC, London, Ont.
  • Author Footnotes
    1 Comité d’expertise du Guide factuel de pratique clinique de la Société canadienne d’ophtalmologie pour la gestion du glaucome chez l’adulte: Paul E. Rafuse, MD PhD FRCSC (président), Halifax, N.-É; Yvonne M. Buys, MD FRCSC, Toronto, Ont.; Karim F. Damji, MD MBA FRCSC, Edmonton, Alb.; Paul Harasymowycz, MD FRCSC, Montréal, Qc.; Caroline Lajoie, MD, MSc, FRCSC, DABO, Québec, Qc.; Frederick S. Mikelberg MD FRCSC, Vancouver, C.-B; Paul H. Murphy, MD FRCSC, Saskatoon, Sask.; Marcelo Nicolela, MD FRCSC, Halifax, N.-É; David P. Tingey, MD FRCSC, London, Ont.
DOI:https://doi.org/10.1016/S0008-4182(09)80037-9
Guide factuel de pratique clinique de la Société canadienne d’ophtalmologie pour la gestion du glaucome chez l’adulte
Previous ArticleCanadian Ophthalmological Society evidence-based clinical practice guidelines for the management of glaucoma in the adult eye
      This paper is only available as a PDF. To read, Please Download here.

      Keywords

      Références

        • Davis D
        • Golman J
        • Palda VA
        Handbook on Clinical Practice Guidelines. Canadian Medical Association, Ottawa, ON2007
        • Jacobsen PD
        Transforming clinical practice guidelines into legislative mandates. Proceed with abundant caution.
        JAMA. 2007; 299: 208-210
        • Canadian Diabetes Association Clinical Practice Guideline Expert Committee
        Canadian Diabetes Association Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada.
        Can J Diabetes. 2008; 32: S1-S201
        • Canadian Hypertension Education Program
        2008 CHEP Recommendations for the Management of Hypertension.
        (Available at:)
        http://hypertension.ca/chep/wp-content/uploads/2008/03/2008-chepspiral-booklet-final_jan28.pdf
        (Accessed March 23, 2009)
        • AGREE Collaboration
        Appraisal of Guidelines for Research & Evaluation (AGREE) Instrument. 2001; (Available at:) (Accessed March 15, 2009)
        http://agreecollaboration.org
        • Gordon MA
        • Beiser JA
        • Brandt JD
        • et al.
        The Ocular Hypertension Treatment Study: Baseline factors that predict the onset of primary open-angle glaucoma.
        Arch Ophthalmol. 2002; 120: 714-720
        • Leske MC
        • Wu SY
        • Hennis A
        • Honaknen R
        • Nemesure B
        • BESs Study Group
        Risk factors for incident openangle glaucoma: the Barbados Eye Studies.
        Ophthalmology. 2008; 115: 85-93
        • Dielemans I
        • Vingerling JR
        • Wolfs RC
        • et al.
        The prevalence of open-angle glaucoma in a population-based study in the Netherlands. The Rotterdam Study.
        Ophthalmol. 1994; 101: 1851-1855
        • Sommer A
        • Tielsch JM
        • Katz J
        • et al.
        Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey.
        Arch Ophthalmol. 1991; 109: 1090-1095
        • Mitchell P
        • Smith W
        • Attebo K
        • Healey PR
        Prevalence of open-angle glaucoma in Australia—The Blue Mountains Eye Study.
        Ophthalmology. 1996; 103: 1661-1669
        • AGIS Investigators
        The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.
        Am J Ophthalmol. 2000; 130: 429-440
        • Collaborative Normal-Tension Glaucoma Study Group
        Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures.
        Am J Ophthalmol. 1998; 126: 487-497
        • Leske MC
        • Heijl A
        • Hussein M
        • Bengtsson B
        • Hyman L
        • Komaroff E
        • Early Manifest Glaucoma Trial Group
        Factors for glaucoma progression and the effect of treatment.
        Arch Ophthalmol. 2003; 121: 48-56
      14. Congenital glaucomas.
        in: Allingham RR Damji KF Freedman S Moroi SE Shafranvo G Shield’s Textbook of Glaucoma. 5th ed. Lippincott Williams & Wilkins, Baltimore, Md.2005: 235-251
      15. Morrison JC Pollack IP Glaucoma: Science and Practice. Thieme, New York, N.Y.2003
      16. Stamper RL Lieberman MF Drake MV Becker-Shaffer’s: Diagnosis and Therapy of the Glaucomas. 7th ed. Mosby, St. Louis, Mo.1999
        • Walton DS
        • Katsavounido G
        Newborn primary congenital glaucoma: 2005 update.
        J Pediatr Ophthalmol Strabismus. 2005; 42: 333-341
        • Greenfield DS
        Glaucoma associated with elevated episcleral venous pressure.
        J Glaucoma. 2000; 9: 190-194
        • Alwards WLM
        Gonioscopy.org. A Video Atlas.
        (Available at:)
        http://www.gonioscopy.org/
        (Accessed December 16, 2008.)
        • Iwase A
        • Suzuki Y
        • Araie M
        • et al.
        • Tajimi Study Group, Japan Glaucoma Society
        The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study.
        Ophthalmology. 2004; 111: 1641-1648
        • Lee BL
        • Gutierrez P
        • Gordon M
        • et al.
        The Glaucoma Symptom Scale. A brief index of glaucoma-specific symptoms.
        Arch Ophthalmol. 1998; 116: 861-866
        • Quigley HA
        • Friedman DS
        • Congdon NG
        Possible mechanisms of primary angle closure and malignant glaucoma.
        J Glaucoma. 2003; 12: 167-180
        • Mandell MA
        • Pavlin CJ
        • Weisbrod DJ
        • Simpson ER
        Anterior chamber depth in plateau iris syndrom and pupillary block as measured by ultrasound biomicroscopy.
        Am J Ophthalmol. 2003; 136: 900-903
        • Pavlin CJ
        • Ritch R
        • Foster FS
        Ultrasound biomicroscopy in plateau iris syndrome.
        Am J Ophthalmol. 1992; 113: 390-395
        • Ritch R
        • Schlotzer-Schrehardt U
        Exfoliation syndrome.
        Surv Ophthalmol. 2001; 45: 265-315
        • Wishart PK
        • Spaeth GL
        • Poryzees EM
        Anterior chamber angle in the pseudoexfoliation syndrome.
        Br J Ophthalmol. 1985; 69: 103-107
        • Gross FJ
        • Tingey D
        • Epstein DL
        Increased prevalence of oc-cludable angles and angle-closure glaucoma in patients with pseudoexfoliation.
        Am J Ophthalmol. 1994; 117: 333-336
        • Speakman JS
        Pigmentary dispersion.
        Br J Ophthalmol. 1981; 65: 249-251
        • Ritch R
        Pigment dispersion syndrome.
        Am J Ophthalmol. 1998; 126: 442-445
        • Kaufman JH
        • Tolpin DW
        Glaucoma after traumatic angle recession: a ten year prospective study.
        Am J Ophthalmol. 1974; 79: 648-654
        • Vasconcelos-Santos DV
        • Nehemy PG
        • Schachat AP
        • Nehemy MB
        Secondary ocular hypertension after intravitreal injection of 4 mg of triamcinolone acetonide: incidence and risk factors.
        Retina. 2008; 28: 573-580
        • Hayreh SS
        Neovascular glaucoma.
        Prog Retin Eye Res. 2007; 26: 470-485
      33. Classification of the glaucomas.
        in: Allingham RR Damji KF Freedman S Moroi SE Shafranvo G Shield’s Textbook of Glaucoma. 5th ed. Lippincott Williams & Wil-kins, Baltimore, Md.2005: 155-162
        • Hyams SW
        • Keroub C
        • Pokotilo E
        Mixed glaucoma.
        Br J Oph-thalmol. 1977; 61: 105-106
        • Resnikoff S
        • Pascolini D
        • Etaya’ale D
        • et al.
        Global data on visual impairment in the year 2002.
        Bull WHO. 2004; 82: 844-851
        • Foster PJ
        • Johnson GJ
        Glaucoma in China: how big is the problem?.
        Br J Ophthalmol. 2001; 85: 1277-1282
        • Quigley HA
        • Broman AT
        The number of people with glaucoma worldwide in 2010 and 2020.
        Br J Ophthalmol. 2006; 90: 262-267
        • Leske MC
        Open-angle glaucoma: An epidemiologic review.
        Ophthalmic Epidemiol. 2007; 14: 166-172
        • Friedman DS
        • Wolfs RC
        • O’Colmain BJ
        • et al.
        • Eye Diseases Prevalence Research Group
        Prevalence of open-angle glaucoma among adults in the United States.
        Arch Ophthalmol. 2004; 122: 532-538
        • Quigley HA
        • West SK
        • Rodrigues J
        • Muñoz B
        • Klein R
        • Sny-der R
        The prevalence of glaucoma in a population-based study of Hispanic subjects: Proyecto VER.
        Arch Ophthalmol. 2001; 119: 1819-1826
        • Perruccio AV
        • Badley EM
        • Trope GE
        Self-reported glaucoma in Canada: findings from population-based surveys, 1994-2003.
        Can J Ophthalmol. 2007; 42: 219-226
        • Maberley DAL
        • Holland H
        • Chuo J
        • et al.
        The prevalence of low vision and blindness in Canada.
        Eye. 2006; 20: 341-346
        • Hirsch JD
        • Morello C
        • Singh R
        • et al.
        Pharmacoeconomics of new medications for common chronic ophthalmic diseases.
        Surv Ophthalmol. 2007; 52: 618-633
      44. Wilson JMG Jungner G Principes et Pratique du Dépistage des Maladies. World Health Organization, Geneva, Switzerland1970 (Cahiers de Santé Publique No 34. ISBN: 92 4 2300349. Available at:)
        http://www.who.int
        (Accessed November 8, 2004)
        • Patterson C
        Screening for visual impairment in the elderly.
        in: Canadian Task Force on the Periodic Health Examination. The Canadian Guide to Clinical Preventive Health Care. Health Canada, Ottawa, On.1994: 932-942 (Cat. H21-117/1994E. Available at:)
        http://www.hc-sc.gc.ca/hppb/healthcare/pdf/clinical_preventive/s11c78e.pdf
        (Accessed March 1, 2009.)
        • Einarson TR
        • Vicente C
        • Machado M
        • Covert D
        • Trope GE
        • Iskedjian M
        Screening for glaucoma in Canada: a systematic review of the literature.
        Can J Ophthalmol. 2006; 41: 709-721
        • Kass MA
        • Heuer DK
        • Higginbotham EJ
        • et al.
        The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.
        Arch Ophthalmol. 2002; 120: 701-713
        • Heijl A
        • Leske MC
        • Bengtsson B
        • et al.
        • Early Manifest Glaucoma Trial Group
        Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial.
        Arch Ophthalmol. 2002; 120: 1268-1279
        • Chauhan BC
        • Mikelberg FS
        • Balaszi AG
        • LeBlanc RP
        • Lesk MR
        • Trope GE
        • Canadian Glaucoma Study Group
        Canadian Glaucoma Study: 2. Risk factors for the progression of open-angle glaucoma.
        Arch Ophthalmol. 2008; 126: 1030-1036
        • Burr JM
        • Mowatt G
        • Hernandez R
        • et al.
        The clinical effectiveness and cost-effectiveness of screening for open-angle glaucoma: a systematic review and economic evaluation.
        Health Technol Assess. 2007; 11: 1-190
        • Côté B
        • Rodriguez N
        Dépistagepopulationnelduglaucomeprimi-tif à angle ouvert. Agence d’évaluation des technologies et des modes d’intervention en santé, Montreal, QC2007 (Available at:)
        http://www.aetmis.gouv.qc.ca/site/34.970.0.0.1.0.phtml
        (Accessed August 3, 2008)
        • Canadian Task Force on the Periodic Health Examination
        Periodic health examination, 1995 update: 3. Screening for visual problems among elderly patients.
        CMAJ. 1995; 152: 1211-1222
        • Harasymowycz P
        • Kamdeu Fansi A
        • Papamatheakis D
        Screening for primary open-angle glaucoma in the developed world: are we there yet?.
        Can J Ophthalmol. 2005; 40: 477-486
        • Harasymowycz P
        • Papamatheakis D
        • Fansi AK
        • Gresset J
        • Lesk MR
        Validity of screening for glaucomatous optic nerve damage using confocal scanning laser Ophthalmoscopy (Heidelberg Retina Tomograph II) in high-risk populations: a pilot study.
        Ophthalmology. 2005; 112: 2164-2171
      55. Weinreb RN Healy PR Topouzis F World Glaucoma Association Consensus. Glaucoma Screening. Consensus Series 5. Kugler Publications, Amsterdam, The Netherlands2008
        • Tuck MW
        • Crick RP
        The age distribution of primary open angle glaucoma.
        Ophthalmic Epidemiol. 1998; 5: 173-183
        • Rezaie T
        • Child A
        • Hitchings R
        • et al.
        Adult-onset primary open-angle glaucoma caused by mutations in optineurin.
        Science. 2002; 295: 1077-1079
        • Kerrigan-Baumrind LA
        • Quigley HA
        • Pease ME
        • Kerrigan DF
        • Mitchell RS
        Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons.
        Invest Ophthalmol Vis Sci. 2000; 41: 741-748
        • Quaranta GM
        • Vetrugno M
        • Trabucco T
        • Cantatore F
        • Cardia L
        The role of frequency doubling technology (FDT) in glaucoma screening.
        Acta Ophthalmol Scand Suppl. 2000; 232: 21-23
        • Medeiros FA
        • Sample PA
        • Weinreb RN
        Frequency doubling technology perimetry abnormalities as predictors of glaucoma-tous visual field loss.
        Am J Ophthalmol. 2004; 137: 863-871
        • Quigley HA
        • Dunkelberger GR
        • Green WR
        Chronic human glaucoma causing selectively greater loss of large optic nerve fibers.
        Ophthalmology. 1988; 95: 357-363
        • Yamada N
        • Chen PP
        • Mills RP
        • et al.
        Screening for glaucoma with frequency-doubling technology and Damato campimetry.
        Arch Ophthalmol. 1999; 117: 1479-1484
        • Trible JR
        • Schultz RO
        • Robinson JC
        • Rothe TL
        Accuracy of glaucoma detection with frequency-doubling perimetry.
        Am J Ophthalmol. 2000; 129: 740-745
        • Thomas R
        • Bhat S
        • Muliyil JP
        • Parikh R
        • George R
        Frequency doubling perimetry in glaucoma.
        J Glaucoma. 2002; 11: 46-50
        • Tatemichi M
        • Nakano T
        • Tanaka K
        • et al.
        Laterality of the performance of glaucoma mass screening using frequency-doubling technology.
        J Glaucoma. 2003; 12: 221-225
        • Soliman MA
        • de Jong LA
        • Ismaeil AA
        • van den Berg TJ
        • de Smet MD
        Standard achromatic perimetry, short wavelength automated perimetry, and frequency doubling technology for detection of glaucoma damage.
        Ophthalmology. 2002; 109: 444-454
        • Maeda H
        • Tanaka Y
        • Nakamura M
        • Yamamoto M
        Blue-on-yellow perimetry using an Armaly glaucoma screening program.
        Ophthalmologica. 1999; 213: 71-75
        • Chia WL
        • Goldberg I
        • Bauman A
        oculokinetic perimetry chart be improved?.
        Aust NZJ Ophthalmol. 1999; 27: 312-317
        • Chia WL
        • Goldberg I
        • Bauman A
        Evaluation of oculokinetic perimetry.
        Aust NZJ Ophthalmol. 1999; 27: 306-311
        • Sponsel WE
        • Arango S
        • Trigo Y
        • Mensah J
        Clinical classification of glaucomatous visual field loss by frequency doubling perimetry.
        Am J Ophthalmol. 1998; 125: 830-836
        • Christoffersen T
        • Fors T
        • Waage S
        • Holtedahl K
        Glaucoma screening with oculokinetic perimetry in general practice: is its specificity acceptable?.
        Eye. 1995; 9: 36-39
        • Wang F
        • Quigley HA
        • Tielsch JM
        Screening for glaucoma in a medical clinic with photographs of the nerve fiber layer.
        Arch Ophthalmol. 1994; 112: 796-800
        • Bowd C
        • Zangwill LM
        • Berry C
        • et al.
        Detecting early glaucoma by assessment of retinal nerve fiber layer thickness and visual function.
        Invest Ophthalmol Vis Sci. 2001; 42: 1993-2003
        • Ntim-Amponsah CT
        Intraocular pressure asymmetry—Topcon Computerized Tonometer CT-20.
        West Afr J Med. 1997; 16: 191-194
        • Swindale NV
        • Stjepanovic G
        • Chin A
        • Mikelberg F
        Automated analysis of normal and glaucomatous optic nerve head topography images.
        Invest Ophthalmol Vis Sci. 2000; 41: 1730-1742
        • Tuulonen A
        • Ohinmaa A
        • Alanko HI
        • Hyytinen P
        • Juutinen A
        • Toppinen E
        The application of teleophthalmology in examining patients with glaucoma: a pilot study.
        J Glaucoma. 1999; 8: 367-373
        • Li HK
        • Tang RA
        • Oschner K
        • Koplos C
        • Grady J
        • Crump WJ
        Telemedicine screening of glaucoma.
        Telemed J. 1999; 5: 283-290
        • Yogesan K
        • Constable IJ
        • Eikelboom RH
        • van Saarloos PP
        Teleophthalmic screening using digital imaging devices.
        Aust NZJ Ophthalmol. 1998; 26: S9-11
        • Taylor JR
        • Pezzullo ML
        • Keeffe JE
        The economic impact and cost of visual impairment in Australia.
        Br J Ophthalmol. 2006; 90: 272-275
        • Schmier JK
        • Halpem MT
        • Jones ML
        The economic implications of glaucoma: a literature review.
        Pharmacoeconomics. 2007; 25: 287-308
        • Rein DB
        • Zhang P
        • Wirthe KE
        • et al.
        The economic burden of major adult visual disorders in the United States.
        Arch Ophthalmol. 2006; 124: 1754-1760
        • Frick KD
        • Gower EW
        • Kempen JH
        • Wolff JL
        Economic impact of visual impairment and blindness in the United States.
        Arch Ophthalmol. 2007; 125: 544-550
        • Kobelt-Nguyen G
        • Gerdtham UG
        • Alm A
        Costs of treating primary open-angle glaucoma and ocular hypertension: a retrospective, observation two-year chart review of newly diagnosed patients in Sweden and the United States.
        J Glaucoma. 1998; 7: 95-104
        • Traverso CE
        • Walt JG
        • Kelly SP
        • et al.
        Direct costs of glaucoma and severity of the disease; a multinational long term study of resource utilization in Europe.
        Br J Ophthalmol. 2005; 89: 1245-1249
        • Lee PP
        • Walt JG
        • Doyle JJ
        • et al.
        A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma.
        Arch Ophtahlmol. 2006; 124: 12-19
        • Lee PP
        • Kelly SP
        • Mills RP
        • et al.
        • Costs of Glaucoma Study Group
        Glaucoma in the United States and Europe: predicting costs and surgical rates based upon stage of disease.
        J Glaucoma. 2007; 16: 471-478
        • Lee PP
        • Levin LA
        • Walt JG
        • et al.
        Cost of patients with primary open-angle glaucoma: a retrospective study of commercial insurance claims data.
        Ophthalmology. 2007; 114: 1241-1247
        • Kymes SM
        • Kass MA
        • Anderson DR
        • Miller JP
        • Gordon MO
        • Ocular Hypertension Treatment Study Group
        Management of ocular hypertension: a cost-effectiveness approach from the Ocular Hypertension Treatment Study.
        Am J Ophthalmol. 2006; 141: 997-1008
        • Stewart WC
        • Stewart JA
        • Nassar QJ
        • Mychaskiw MA
        Costeffectiveness of treating ocular hypertension.
        Ophthalmology. 2008; 115: 94-98
        • Thygesen J
        • Aagren M
        • Amavielle S
        • et al.
        Late-stage, primary open-angle glaucoma in Europe: social and health care maintenance costs and quality of life of patients from 4 countries.
        Curr Med Res Opin. 2008; 24: 1763-1770
        • Iskedjian M
        • Walker J
        • Vicente C
        • Trope GE
        • Buys Y
        • Einarson TR
        • Covert D
        Cost of glaucoma in Canada: analyses based on visual field and physician's assessment.
        J Glaucoma. 2003; 12: 456-462
        • Canadian Ophthalmological Society Clinical Practice Guideline Expert Committee
        Canadian Ophthalmological Society evidence-based clinical practice guidelines for the periodic eye examination in adults in Canada.
        Can J Ophthalmol. 2007; 42: 39-45
        • Greenfield DS
        • Siatkowski RM
        • Glaser JS
        • Schatz NJ
        • Parrish 2nd, RK
        The cupped disc. Who needs neuroimaging?.
        Ophthalmology. 1998; 105: 1866-1874
        • Le A
        • Mukesh BN
        • McCarty CA
        • Taylor R
        Risk factors associated with incidence of open-angle glaucoma: the visual impairment project.
        Invest Ophthalmol Vis Sci. 2003; 44: 3783-3789
        • Nemesure B
        • Leske MC
        • He Q
        • Mendell N
        Analysis of reported family history of glaucoma: a preliminary investigation. The Barbados Eye Study Group.
        Ophthalmic Epidemiol. 1996; 3: 135-141
        • Wolfs RC
        • Klaver CC
        • Ramrattan RS
        • van Duijn CM
        • Hofman A
        • de Jong PT
        v. Population-based familial aggregation study.
        Arch Ophthalmol. 1998; 116: 1640-1645
        • Kaimbo DK
        • Buntinx F
        • Missotten L
        Risk factors for open-angle glaucoma: a case-control study.
        J Clin Epidemiol. 2001; 54: 166-171
        • Tielsch JM
        • Katz J
        • Sommer A
        • Quigley HA
        • Javitt JC
        • et al.
        Family history and the risk of primary open angle glaucoma. The Baltimore Eye Survey.
        Arch Ophthalmol. 1994; 112: 69-73
        • Nemesure B
        • He Q
        • Mendell N
        • et al.
        • Barbados Family Study Group
        Inheritance of open-angle glaucoma in the Barbados family study.
        Am J Med Genet. 2001; 103: 36-43
        • Nguyen RL
        • Raja SC
        • Traboulsi EI
        Screening relatives of patients with familial chronic open angle glaucoma.
        Ophthalmology. 2000; 107: 1294-1297
        • Wickham L
        • Edmunds B
        • Murdoch IE
        Can the current oculokinetic perimetry chart be improved?.
        Ophthalmology. 2005; 112: 225-228
        • Dueker DK
        • Singh K
        • Lin SC
        • et al.
        Corneal thickness measurement in the management of primary open angle glaucoma. A report by the American Academy of Ophthalmology.
        Ophthalmology. 2007; 114: 1779-1787
        • Hoskins Jr, HD
        • Kass MA
        Gonioscopy.
        in: Becker-Shaffer's Diagnosis and Therapy of the Glaucomas. 6th ed. Mosby, St. Louis, Mo.1989: 106-116
      104. Tasman W Jaeger EA Duane's Clinical Ophthalmology. JB Lippincott Co, Philadelphia, Pa2004
        • Kirwan JF
        • Gouws P
        • Linnell AE
        • Crowston J
        • Bunce C
        Pharmacological mydriasis and optic disc examination.
        Br J Ophthalmol. 2000; 84: 894-898
        • Ariyasu RG
        • Lee PP
        • Linton KP
        • LaBree LD
        • Azen SP
        • Siu AL
        Sensitivity, specificity, and predictive values of screening tests for eye conditions in a clinic-based population.
        Ophthalmology. 1996; 103: 1751-1760
        • Batchelder TJ
        • Fireman B
        • Friedman GD
        • et al.
        The value of routine dilated pupil screening examination.
        Arch Ophthalmol. 1997; 115: 1179-1184
        • Ferraro JG
        • Mazzoni LL
        • Keeffe JE
        • Vu HT
        • Constantinou M
        • Taylor HR
        Evaluation of an eye health program: the vision initiative.
        Ophthalmic Epidemiol. 2006; 13: 127-135
        • Taylor HR
        • Vu HT
        • McCarty CA
        • Keeffe JE
        The need for routine eye examinations.
        Invest Ophthalmol Vis Sci. 2004; 45: 2539-2542
        • Leske MC
        • Wu SY
        • Nemesure B
        • Hennis A
        Incident open-angle glaucoma and blood pressure.
        Arch Ophthalmol. 2002; 120: 954-959
        • Jonas JB
        • Gusek GC
        • Naumann GO
        Optic disc, cup and neuroretinal rim size, configuration and correlations in normal eyes.
        Invest Ophthalmol Vis Sci. 1988; 29: 1151-1158
        • Jonas JB
        • Gusek GC
        • Naumann GO
        Optic disc morphom-etry in chronic primary open-angle glaucoma, I: morphometric intrapapillary characteristics.
        Graefes Arch Clin Exp Ophthalmol. 1988; 226: 522-530
        • Harizman N
        • Oliveira C
        • Chiang A
        • et al.
        The ISNT rule and differentiation of normal from glaucomatous eyes.
        Arch Ophthalmol. 2006; 124: 1579-1583
        • Quigley HA
        • Varma R
        • Tielsch JM
        • Katz J
        • Sommer A
        • Gilbert DL
        The relationship between optic disc area and open-angle glaucoma: the Baltimore Eye Survey.
        J Glaucoma. 1999; 8: 347-352
        • Healey PR
        • Mitchell P
        Optic disc size in open-angle glaucoma: the Blue Mountains Eye Study.
        Am J Ophthalmol. 1999; 128: 515-517
        • Jonas JB
        • Budde WM
        • Lang PJ
        Parapapillary atrophy is associated with chronic open-angle glaucomas.
        Graefes Arch Clin Exp Ophthalmol. 1999; 237: 793-799
        • Park KH
        • Tomita G
        • Liou SY
        • Kitazawa Y
        Correlation between peripapillary atrophy and optic nerve damage in normal-tension glaucoma.
        Ophthalmology. 1996; 103: 1899-1906
        • Diehl DL
        • Quigley HA
        • Miller NR
        • Sommer A
        • Burney EN
        Prevalence and significance of optic disc hemorrhage in a longitudinal study of glaucoma.
        Arch Ophthalmol. 1990; 108: 545-550
        • Healey PR
        • Mitchell P
        • Smith W
        • Wang JJ
        Optic disc hemorrhages in a population with and without signs of glaucoma.
        Ophthalmology. 1998; 105: 216-223
        • Mitchell P
        • Wang JJ
        • Hourihan F
        The relationship between glaucoma and pseudoexfoliation. The Blue Mountains Eye Study.
        Arch Ophthalmol. 1999; 117: 1319-1324
        • Foster PJ
        • Machin D
        • Wong TY
        • et al.
        Determinants of intraocular pressure and its association with glaucomatous optic neuropathy in Chinese Singaporeans: the Tanjong Pagar Study.
        Invest Ophthalmol Vis Sci. 2003; 44: 3885-3891
        • Nemesure B
        • Wu SY
        • Hennis A
        • Leske MC
        • Barbados Eye Study Group
        Corneal thickness and intraocular pressure in the Barbados Eye Studies.
        Arch Ophthalmol. 2003; 121: 240-244
        • Vijaya L
        • George R
        • Paul PG
        • et al.
        Prevalence of open-angle glaucoma in a rural south Indian population.
        Invest Ophthalmol Vis Sci. 2005; 46: 4461-4467
        • Siddiqui Y
        • Ten Hulzen RD
        • Cameron JD
        • Hodge DO
        • Johnson DH
        What is the risk of developing pigmentary glaucoma from pigment dispersion syndrome?.
        Am J Ophthalmol. 2003; 135: 794-799
        • Mitchell P
        • Hourihan F
        • Sandbach J
        • Wang JJ
        The relationship between glaucoma and myopia: the Blue Mountains Eye Study.
        Ophthalmology. 1999; 106: 2010-2015
        • Ramakrishnan R
        • Nirmalan PK
        • Krishnadas R
        • et al.
        Glaucoma in a rural population of southern India: the Aravind comprehensive eye survey.
        Ophthalmology. 2003; 110: 1484-1490
        • Martinez GC
        • Campbell AJ
        • Reinken J
        • Allan BC
        Prevalence of ocular disease in a population study of subjects 65 years old and older.
        Am J Ophthalmol. 1982; 91: 181-189
        • Leske MC
        • Connell AM
        • Wu SY
        • et al.
        Risk factors for open-angle glaucoma: the Barbados Eye Study.
        Arch Ophthalmol. 1995; 113: 918-924
        • Mukesh BN
        • McCarty CA
        • Rait JL
        • Taylor HR
        Five-year incidence of open-angle glaucoma: the visual impairment project.
        Ophthalmology. 2002; 109: 1047-1051
        • Tielsch JM
        • Sommer A
        • Katz J
        • Royall RM
        • Quigley HA
        • Javitt J
        Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey.
        JAMA. 1991; 266: 369-374
        • Leske MC
        • Connell AM
        • Schachat AP
        • et al.
        • The Barbados Eye Study
        Prevalence of open angle glaucoma.
        Arch Ophthalmol. 1994; 112: 821-829
        • Friedman DS
        • Jampel HD
        • Munõz B
        • West SK
        The prevalence of open-angle glaucoma among blacks and whites 73 years and older: the Salisbury Eye Evaluation Study.
        Arch Ophthalmol. 2006; 121: 1625-1630
        • Stone EM
        • Fingert JH
        • Alward WL
        • et al.
        Identification of a gene that causes primary open angle glaucoma.
        Science. 1997; 275: 668-670
        • Aung T
        • Ocaka L
        • Ebenezer ND
        • et al.
        A major marker for normal tension glaucoma: association with polymorphisms in the OPA1 gene.
        Hum Genet. 2002; 110: 52-62
        • Copin B
        • Brézin AP
        • Valtot F
        • Dascotte JC
        • Béchetoille A
        • Garchon HJ
        Apolipoprotein E-promoter single-nucleotide polymorphisms affect the phenotype of primary open-angle glaucoma and demonstrate interaction with the myocilin gene.
        Am J Hum Genet. 2002; 70: 1575-1581
        • Vickers JC
        • Craig JE
        • Stankovich J
        • et al.
        The apolipoprotein epsilon4 gene is associated with elevated risk of normal tension glaucoma.
        Mol Vis. 2002; 8: 389-393
        • Phelps CD
        • Corbett JJ
        Migraine and low-tension glaucoma. A case-control study.
        Invest Ophthalmol Vis Sci. 1985; 26: 1105-1108
        • Wang JJ
        • Mitchell P
        • Smith W
        Is there an association between migraine headache and open-angle glaucoma? Findings from the Blue Mountain Eye Study.
        Ophthalmology. 1997; 104: 1714-1719
        • Drance S
        • Anderson DR
        • Schulzer M
        • Collaborative Normal-Tension Glaucoma Study Group
        Risk factors for progression of visual field abnormalities in normal-tension glaucoma.
        Am J Ophthalmol. 2001; 131: 699-708
        • Garbe E
        • LeLorier J
        • Boivin JF
        • Suissa S
        Risk of ocular hypertension or open angle glaucoma in elderly patients on oral glucocorticoids.
        Lancet. 1997; 350: 979-982
        • Mitchell P
        • Cumming RG
        • Mackey DA
        Inhaled corticoster-oids, family history, and risk of glaucoma.
        Ophthalmology. 1999; 106: 2301-2306
        • Quigley HA
        • Enger C
        • Katz J
        • Sommer A
        • Scott R
        • Gilbert D
        Risk factors for the development of glaucomatous visual field loss in ocular hypertension.
        Arch Ophthalmol. 1994; 112: 619-644
        • Landers J
        • Goldberg I
        • Graham SL
        Analysis of risk factors that may be associated with progression from ocular hypertension to primary open angle glaucoma.
        Clin Experiment Ophthalmol. 2002; 30: 242-247
        • Thomas R
        • Parikh R
        • George R
        • Kumar RS
        • Muliyil J
        Five-year risk of progression of ocular hypertension to primary open angle glaucoma. A population-based study.
        Indian J Ophthal-mol. 2003; 51: 329-333
        • Zangwill LM
        • Weinreb RN
        • Beiser JA
        • et al.
        Baseline topographic optic disc measurements are associated with the development of primary open-angle glaucoma: the Confocal Scanning Laser Ophthalmoscopy Ancillary Study to the Ocular Hypertension Treatment Study.
        Arch Ophthalmol. 2005; 123: 1188-1197
        • Budenz DL
        • Anderson DR
        • Feuer WJ
        • et al.
        Ocular hypertension treatment study group. Detection and prognostic significance of optic disc hemorrhages during the ocular hypertension treatment study.
        Ophthalmology. 2006; 113: 2137-2143
        • Perkins ES
        • Phelps CD
        Open angle glaucoma, ocular hypertension, low-tension glaucoma, and refraction.
        Arch Ophthalmol. 1982; 100: 1464-1467
        • Weinreb RN
        • Friedman DS
        • Fechtner RD
        • et al.
        Risk assessment in the management of patients with ocular hypertension.
        Am J Ophthalmol. 2004; 138: 458-467
        • Bill A
        Some aspects of aqueous humour drainage.
        Eye. 1993; 7: 14-19
        • Kitazawa Y
        • Horie T
        Diurnal variation of intraocular pressure in primary open-angle glaucoma.
        Am J Ophthalmol. 1975; 79: 557-566
        • Newell FW
        • Krill AE
        Diurnal tonography in normal and glau-comatous eyes.
        Trans Am Ophthalmol Soc. 1964; 62: 349-374
        • Whitacre MM
        • Stein R
        Sources of error with use of Goldmanntype tonometers.
        Surv Ophthalmol. 1993; 38: 1-30
      153. Intraocular pressure and tonometry.
        in: Allingham RR Damji KF Freedman S Moroi SE Shafranvo G Shields' Textbook of Glaucoma. 5th ed. Lippincott Williams & Wilkins, Baltimore, Md.2005: 36-58
        • Damji KF
        • Muni RH
        • Munger RM
        Influence of corneal variables on accuracy of intraocular pressure measurement.
        J Glaucoma. 2003; 12: 69-80
        • South East Asia Glaucoma Interest Group
        Asia Pacific Glaucoma Guidelines. 2nd ed. Scientific Communications, Hong Kong2008: 1-117
        • Shields MB
        The non-contact tonometer. Its value and limitations.
        Surv Ophthalmol. 1980; 24: 211-219
        • Faucher A
        • Grégoire J
        • Blondeau P
        Accuracy of Goldmann tonometry after refractive surgery.
        J Cataract Refract Surg. 1997; 23: 832-838
        • Phelps CD
        • Phelps GK
        Measurement of intraocular pressure: a study of its reproducibility.
        Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1976; 198: 39-43
        • Whitacre MM
        • Stein RA
        • Hassanein K
        The effect of cor- neal thickness on applanation tonometry.
        Am J Ophthalmol. 1993; 115: 592-599
        • Damji KF
        • Behki R
        • Wang L
        • et al.
        Canadian perspectives in glaucoma management: setting target intraocular pressure range.
        Can J Ophthalmol. 2003; 38: 189-197
        • Behki R
        • Damji KF
        • Crichton A
        • CCT workshop participants
        Canadian perspectives in glaucoma management: the role of central corneal thickness.
        Can J Ophthalmol. 2007; 42: 66-74
        • Brandt JD
        Central corneal thickness, tonometry, and glaucoma risk-a guide for the perplexed.
        Can J Ophthalmol. 2007; 42: 562-566
        • Miglior S
        • Pfeiffer N
        • Torri V
        • Zeyen T
        • Cunha-Vaz J
        • Adamsons I
        • European Glaucoma Prevention Study (EGPS) Group
        Predictive factors for open-angle glaucoma among patients with ocular hypertension in the European Glaucoma Prevention Study.
        Ophthalmology. 2007; 114: 3-9
        • Brandt JD
        • Beiser JA
        • Gordon MO
        • Kass MA
        • Ocular Hypertension Treatment Study Group
        Central corneal thickness and measured IOP response to topical ocular hypotensive medication in the Ocular Hypertension Treatment Study.
        Am J Ophthalmol. 2004; 138: 717-722
        • Aakre BM
        • Doughty MJ
        • Dalane OV
        • Berg A
        • Aamodt O
        • Gangstad H
        Assessment of reproducibility of measures of intraocular pressure and central corneal thickness in young white adults over a 16-h time period.
        Ophthalmic Physiol Opt. 2003; 23: 271-283
        • McMillan F
        • Forester RK
        Comparison of the MacKay-Marg, Goldmann and Perkins tonometers in abnormal corneas.
        Arch Ophthalmol. 1975; 93: 420-424
        • Stelzer R
        Die beziehunger des innendruckes zur auberen applanation der hornhaut enucleierter augen.
        Graefes Arch Klin Ophthalmol. 1974; 189: 33-41
        • Moses RA
        The Goldmann applanation tonometer.
        Am J Ophthalmol. 1958; 46: 865-869
        • Simon G
        • Small RH
        • Ren Q
        • Parel J-M
        Effect of corneal hydration on Goldmann applanation tonometry and corneal topography.
        Refract Corneal Surg. 1993; 9: 110-117
        • Kaufman HE
        Pressure measurement: Which tonometer?.
        Invest Ophthal. 1972; 11: 80-85
        • Bathija R
        • Zangwill L
        • Berry CC
        • Sample PA
        • Weinreb RN
        Detection of early glaucomatous structural damage with confocal scanning laser tomography.
        J Glaucoma. 1998; 7: 121-127
        • Bowd C
        • Chan K
        • Zangwill LM
        • et al.
        Comparing neural networks and linear discriminant functions for glaucoma detection using confocal scanning laser ophthalmoscopy of the optic disc.
        Invest Ophthalmol Vis Sci. 2002; 43: 3444-3454
        • Iester M
        • Mardin CY
        • Budde WM
        • Jünemann AG
        • Hayler JK
        • Jonas JB
        Discriminant analysis formulas of optic nerve head parameters measured by confocal scanning laser tomography.
        J Glaucoma. 2002; 11: 97-104
        • Zangwill LM
        • Weinreb RN
        • Berry CC
        • et al.
        Racial differences in optic disc topography: baseline results from the Con-focal Scanning Laser Ophthalmoscopy Ancillary Study to the Ocular Hypertension Treatment Study.
        Arch Ophthalmol. 2004; 122: 22-28
        • Nicolela MT
        • Soares AS
        • Carillo MM
        • Chauhan BC
        • LeBlanc RP
        • Artes PH
        Effect of moderate intraocular pressure changes on topographic measurements with confocal scanning laser tomography in patients with glaucoma.
        Arch Ophthalmol. 2006; 124: 633-640
        • Medeiros FA
        • Zangwill LM
        • Bowd C
        • Vasile C
        • Sample PA
        • Weinreb RA
        Agreement between stereophotographic and con-focal scanning laser ophthalmoscopy measurements of cup/disc ratio: effect on a predictive model for glaucoma development.
        J Glaucoma. 2007; 16: 209-214
        • Wollstein G
        • Schuman JS
        • Price LL
        • et al.
        Optical coherence tomography (OCT) macular and peripapillary retinal nerve fiber layer measurements and automated visual fields.
        Am J Ophthalmol. 2004; 138: 218-225
        • Budenz DL
        • Chang RT
        • Huang X
        • Knighton RW
        • Tielsch JM
        Reproducibility of retinal nerve fiber thickness measurements using the stratus OCT in normal and glaucomatous eyes.
        Invest Ophthalmol Vis Sci. 2005; 46: 2440-2443
        • Leung CK
        • Chong KK
        • Chan WM
        • et al.
        Comparative study of retinal nerve fiber layer measurement by Stratus OCT and GDx VCC, II: structure/function regression analysis in glaucoma.
        Invest Ophthalmol Vis Sci. 2005; 46: 3702-3711
        • Arthur SN
        • Aldridge AJ
        • De León-Ortega J
        • McGwin G
        • Xie A
        • Girkin CA
        Agreement in assessing cup-to-disc ratio measurement among stereoscopic optic nerve head photographs, HRT II, and Stratus OCT.
        J Glaucoma. 2006; 15: 183-189
        • Parikh RS
        • Parikh S
        • Sekhar GC
        • et al.
        Diagnostic capability of optical coherence tomography (Stratus OCT 3) in early glaucoma.
        Ophthalmology. 2007; 114: 2238-2243
        • Weinreb RN
        • Bowd C
        • Zangwill LM
        Scanning laser polarimetry in monkey eyes using variable corneal polarization compensation.
        J Glaucoma. 2002; 11: 378-384
        • Bagga H
        • Greenfield DS
        • Feuer W
        • Knighton RW
        Scanning laser polarimetry with variable corneal compensation and optical coherence tomography in normal and glaucomatous eyes.
        Am J Ophthalmol. 2003; 135: 521-529
        • Choi J
        • Cho HS
        • Lee CH
        • Kook MS
        Scanning laser polarim-etry with variable corneal compensation in the area of apparently normal hemifield in eyes with normal-tension glaucoma.
        Ophthalmology. 2006; 113: 1954-1960
        • Reus NJ
        • Zhou Q
        • Lemij HG
        Enhanced imaging algorithm for scanning laser polarimetry with variable corneal compensation.
        Invest Ophthalmol Vis Sci. 2006; 47: 3870-3877
        • Bowd C
        • Medeiros FA
        • Weinreb RN
        • Zangwill LM
        The effect of atypical birefringence patterns on glaucoma detection using scanning laser polarimetry with variable corneal compensation.
        Invest Ophthalmol Vis Sci. 2007; 48: 223-227
        • Medeiros FA
        • Bowd C
        • Zangwill LM
        • Patel C
        • Weinreb RA
        Detection of glaucoma using scanning laser polarimetry with enhanced corneal compensation.
        Invest Ophthalmol Vis Sci. 2007; 48: 3146-3153
        • Sehi M
        • Ume S
        • Greenfield DS
        Scanning laser polarimetry with enhanced corneal compensation and optical coherence tomography in normal and glaucomatous eyes.
        Invest Ophthalmol Vis Sci. 2007; 48: 2099-2104
        • Kwartz AJ
        • Henson DB
        • Harper RA
        • Spencer AF
        • McLeod D
        The effectiveness of the Heidelberg Retina Tomograph and laser diagnostic glaucoma scanning system (GDx) in detecting and monitoring glaucoma.
        Health Technol Assess. 2005; 9 (iii): 1-132
        • Medeiros FA
        • Zangwill LM
        • Bowd C
        • Sample PA
        • Weinreb RA
        Influence of disease severity and optic disc size on the diagnostic performance of imaging instruments in glaucoma.
        Invest Ophthalmol Vis Sci. 2006; 47: 1008-1015
        • Shunmugam M
        • Azuara-Blanco A
        The quality of reporting of diagnostic accuracy studies in glaucoma using the Heidelberg retina tomograph.
        Invest Ophthalmol Vis Sci. 2006; 47: 2317-2323
        • Johnson ZK
        • Siddiqui MA
        • Azuara-Blanco A
        The quality of reporting of diagnostic accuracy studies of optical coherence tomography in glaucoma.
        Ophthalmology. 2007; 114: 1607-1612
        • Lin SC
        • Singh K
        • Jampel HD
        • et al.
        • Ophthalmic Technology Assessment Committee Glaucoma Panel
        Optic nerve head and retinal nerve fiber layer analysis: a report by the American Academy of Ophthalmology.
        Ophthalmology. 2007; 114: 1937-1949
        • Medeiros FA
        • Zangwill LM
        • Bowd C
        • Weinreb RN
        Comparison of the GDx VCC scanning laser polarimeter, HRT II con-focal scanning laser ophthalmoscope, and stratus OCT optical coherence tomograph for the detection of glaucoma.
        Arch Ophthalmol. 2004; 122: 827-837
        • Deleón-Ortega JE
        • Arthur SN
        • McGwin Jr, G
        • Xie A
        • Monheit BE
        • Girkin CA
        Discrimination between glaucomatous and nonglaucomatous eyes using quantitative imaging devices and subjective optic nerve head assessment.
        Invest Ophthalmol Vis Sci. 2006; 47: 3374-3380
        • Greaney MJ
        • Hoffman DC
        • Garway-Heath DF
        • Nakla M
        • Cole-man A
        • Caprioli J
        Comparison of optic nerve imaging methods to distinguish normal eyes from those with glaucoma.
        Invest Ophthalmol Vis Sci. 2002; 43: 140-145
        • Reus NJ
        • de Graaf M
        • Lemij HG
        Accuracy of GDx VCC, HRT I, and clinical assessment of stereoscopic optic nerve head photographs for diagnosing glaucoma.
        Br J Ophthalmol. 2007; 91: 313-318
        • Kourkoutas D
        • Buys YM
        • Flanagan JG
        • Hatch WV
        • Balian C
        • et al.
        Comparison of glaucoma progression evaluated with Heidelberg retina tomograph II versus optic nerve head stereophotographs.
        Can J Ophthalmol. 2007; 42: 82-88
        • Kamal DS
        • Garway-Heath DF
        • Hitchings RA
        • Fitzke FW
        Use of sequential Heidelberg retina tomograph images to identify changes at the optic disc in ocular hypertensive patients at risk of developing glaucoma.
        Br J Ophthalmol. 2000; 84: 993-998
        • Mohammadi K
        • Bowd C
        • Weinreb RN
        • Medeiros FA
        • Sample PA
        • Zangwill LM
        Retinal nerve fiber layer thickness measurements with scanning laser polarimetry predict glaucomatous visual field loss.
        Am J Ophthalmol. 2004; 138: 592-601
        • Lalezary M
        • Medeiros FA
        • Weinreb RN
        • et al.
        Baseline optical coherence tomography predicts the development of glaucomatous change in glaucoma suspects.
        Am J Ophthalmol. 2006; 142: 576-582
        • Wolfs RC
        • Ramrattan RS
        • Hofman A
        • de Jong PT
        • et al.
        Cup-to-disc ratio: ophthalmoscopy versus automated measurement in a general population: The Rotterdam Study.
        Ophthalmology. 1999; 106: 1597-1601
        • Kamal DS
        • Viswanathan AC
        • Garway-Heath DF
        • Hitchings RA
        • Poinoosawmy D
        • Bunce C
        Detection of optic disc change with the Heidelberg retina tomograph before confirmed visual field change in ocular hypertensives converting to early glaucoma.
        Br J Ophthalmol. 1999; 83: 290-294
        • Chauhan BC
        • McCormick TA
        • Nicolela MT
        • LeBlanc RP
        Optic disc and visual field changes in a prospective longitudinal study of patients with glaucoma: comparison of scanning laser tomography with conventional perimetry and optic disc photography.
        Arch Ophthalmol. 2001; 119: 1492-1499
        • Nicolela MT
        • McCormick TA
        • Drance SM
        • Ferrier SM
        • LeBlanc RP
        • Chauhan BC
        Visual field and optic disc progression in patients with different types of optic disc damage: a longitudinal prospective study.
        Ophthalmology. 2003; 110: 2178-2184
        • Wollstein G
        • Schuman JS
        • Price LL
        • et al.
        Optical coherence tomography longitudinal evaluation of retinal nerve fiber layer thickness in glaucoma.
        Arch Ophthalmol. 2005; 123: 464-470
        • Artes PH
        • Chauhan BC
        Longitudinal changes in the visual field and optic disc in glaucoma.
        Prog Retin Eye Res. 2005; 24: 333-354
        • Coleman AL
        • Sommer A
        • Enger C
        • Knopf HL
        • Stamper RL
        • Minckler DS
        Interobserver and intraobserver variability in the detection of glaucomatous progression of the optic disc.
        J Glaucoma. 1996; 5: 384-389
        • Ervin JC
        • Lemij HG
        • Mills RP
        • Quigley HA
        • Thompson HW
        • Burgoyne CF
        Clinician change detection viewing longitudinal stereophotographs compared to confocal scanning laser tomography in the LSU Experimental Glaucoma (LEG) Study.
        Ophthalmology. 2002; 109: 467-481
        • Azuara-Blanco A
        • Katz LJ
        • Spaeth GL
        • Vernon SA
        • Spencer F
        • Lanzl IM
        Clinical agreement among glaucoma experts in the detection of glaucomatous changes of the optic disk using simultaneous stereoscopic photographs.
        Am J Ophthalmol. 2003; 136: 949-950
        • Quigley HA
        • Addicks EM
        • Green WR
        • Maumenee AE
        Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage.
        Arch Ophthalmol. 1981; 99: 635-649
        • Quigley HA
        • Dunkelberger GR
        • Green WR
        Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma.
        Am J Ophthalmol. 1989; 107: 453-464
        • Bengtsson B
        • Heijl A
        Evaluation of a new perimetric threshold strategy, SITA, in patients with manifest and suspect glaucoma.
        Acta Ophthalmol Scand. 1998; 76: 268-272
        • Artes PH
        • Iwase A
        • Ohno Y
        • Kitazawa Y
        • Chauhan BC
        Properties of perimetric threshold estimates from Full Threshold, SITA Standard, and SITA Fast strategies.
        Invest Ophthalmol Vis Sci. 2002; 43: 2654-2659
        • Gonzales de la Rosa M
        • Morales J
        • Dannheim F
        • et al.
        Multicenter evaluation of tendency-oriented perimetry (TOP) using the G1 grid.
        Eur J Ophthalmol. 2003; 13: 32-41
        • Dacey DM
        • Lee BB
        The ‘blue-on’ opponent pathway in primate retina originates from a distinct bistratified ganglion cell type.
        Nature. 1994; 367: 731-735
        • Martin PR
        • White AJ
        • Goodchild AK
        • Wilder HD
        • Sefton AE
        Evidence that blue-on cells are part of the third geniculocortical pathway in primates.
        Eur J Neurosci. 1997; 9: 1536-1541
        • Johnson CA
        • Adams AJ
        • Casson EJ
        • Brandt JD
        Blue-on-yellow perimetry can predict the development of glaucomatous visual field loss.
        Arch Ophthalmol. 1993; 111: 645-650
        • Girkin CA
        • Emdadi A
        • Sample PA
        • et al.
        Short-wavelength automated perimetry and standard perimetry in the detection of progressive optic disc cupping.
        Arch Ophthalmol. 2000; 118: 1231-1236
        • Johnson CA
        • Sample PA
        • Zangwill LM
        Structure and function evaluation (SAFE): II. Comparison of optic disk and visual field characteristics.
        Am J Ophthalmol. 2003; 135: 148-154
        • Sample PA
        • Medeiros FA
        • Racette L
        • et al.
        Identifying glaucomatous vision loss with visual-function-specific perimetry in the diagnostic innovations in glaucoma study.
        Invest Ophthalmol Vis Sci. 2006; 47: 3381-3389
        • Shabana N
        • Cornilleau-Pérès V
        • Carkeet A
        • Chew PT
        Motion perception in glaucoma patients: a review.
        Surv Ophthalmol. 2003; 48: 92-106
        • Brusini P
        • Salvetat ML
        • Zeppieri M
        • Parisi L
        Frequency doubling technology perimetry with the Humphrey Matrix 30-2 test.
        J Glaucoma. 2006; 15: 77-83
        • Girkin CA
        Relationship between structure of optic nerve/nerve fiber layer and functional measurements in glaucoma.
        Curr Opin Ophthalmol. 2004; 15: 96-101
        • Blumenthal EZ
        • Horani A
        • Sasikumar R
        • Garudadri C
        • Udaykumar A
        • Thomas R
        Correlating structure with function in end-stage glaucoma.
        Ophthalmic Surg Lasers Imaging. 2006; 37: 218-223
        • Heijl A
        • Bengtsson B
        • Chauhan BC
        • et al.
        A comparison of visual field progression criteria of 3 major glaucoma trials in Early Manifest Glaucoma Trial patients.
        Ophthalmology. 2008; Mar 29; ([Epub ahead of print])
        • Haymes SA
        • Hutchison DM
        • McCormick TA
        • et al.
        Glaucomatous visual field progression with frequency-doubling technology and standard automated perimetry in a longitudinal prospective study.
        Invest Ophthalmol Vis Sci. 2005; 46: 547-554
        • Artes PH
        • Hutchison DM
        • Nicolela MT
        • LeBlanc RP
        • Chauhan BC
        Threshold and variability properties of matrix frequency-doubling technology and standard automated perimetry in glaucoma.
        Invest Ophthalmol Vis Sci. 2005; 46: 2451-2457
        • Zalta AH
        Use of a central 10 field and size V stimulus to evaluate and monitor small central islands of vision in end stage glaucoma.
        Br J Ophthalmol. 1991; 75: 151-154
        • Ahmed II
        • Feldman F
        • Kucharczyk W
        • et al.
        Neuroradiologic screening in normal-pressure glaucoma: study results and literature review.
        J Glaucoma. 2002; 11: 279-286
        • O’Brien C
        • Saxton V
        • Crick RP
        • Meire H
        Doppler carotid artery studies in asymmetric glaucoma.
        Eye. 1992; 6: 273-276
        • Leske MC
        • Heijl A
        • Hyman L
        • Bengtsson B
        • Dong L
        • Yang Z
        • EMGT Group
        Predictors of long-term progression in the early manifest glaucoma trial.
        Ophthalmology. 2007; 114: 1965-1972
        • Graham SL
        • Drance SM
        • Wijsman K
        • Douglas GR
        • Mikelberg FS
        Ambulatory blood pressure monitoring in glaucoma. The nocturnal dip.
        Ophthalmology. 1995; 102: 61-69
        • Hayreh SS
        • Zimmerman MB
        • Podhjasky P
        • Alward WL
        Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders.
        Am J Ophthalmol. 1994; 117: 603-624
        • Klein BE
        • Klein R
        • Sponsel WE
        • et al.
        Prevalence of glaucoma. The Beaver Dam Eye Study.
        Ophthalmology. 1992; 99: 1499-1504
        • Shiose Y
        • Kitazaøwa Y
        • Tsukahara S
        • et al.
        Epidemiology of glaucoma in Japan—a nationwide glaucoma survey.
        Jpn J Ophthalmol. 1991; 35: 133-155
        • Anderson DR
        • Drance SM
        • Schulzer M
        • Collaborative Normal-Tension Glaucoma Study Group
        Natural history of normal-tension glaucoma.
        Ophthalmology. 2001; 108: 247-253
        • Campbell DG
        Pigmentary dispersion and glaucoma. A new theory.
        Arch Ophthalmol. 1979; 97: 1667-1672
        • Greenstein VC
        • Seiple W
        • Liebmann J
        • Ritch R
        Retinal pigment epithelial dysfunction in patients with pigment dispersion syndrome: implications for the theory of pathogenesis.
        Arch Ophthalmol. 2001; 119: 1291-1295
        • Karichoff JR
        Pigmentary dispersion syndrome and pigmentary glaucoma: a new mechanism concept, a new treatment, and a new technique.
        Ophthalmic Surg. 1992; 23: 269-277
        • Kanadani FN
        • Dorairaj S
        • Langlieb AM
        • et al.
        Ultrasound biomicroscopy in asymmetric pigment dispersion syndrome and pigmentary glaucoma.
        Arch Ophthalmol. 2006; 124: 1573-1576
        • Lord FD
        • Pathanapitoon K
        • Mikelberg FS
        Keratometry and axial length in pigment dispersion syndrome: a descriptive case-control study.
        J Glaucoma. 2001; 10: 383-385
        • Breingan PJ
        • Esaki K
        • Ishikawa H
        • Liebmann JM
        • Greenfield DS
        • Ritch R
        Iridolenticular contact decreases following laser iridotomy for pigment dispersion syndrome.
        Arch Ophthalmol. 1999; 117: 325-328
        • Kuchle M
        • Nguyen NX
        • Mardin CY
        • Naumann GO
        Effect of neodymium: YAG laser iridotomy on number of aqueous melanin granules in primary pigment dispersion syndrome.
        Graefes Arch Clin Exp Ophthalmol. 2001; 239: 411-415
        • Reistsad CE
        • Shields MD
        • Campbell DG
        • Ritch R
        • Wang JC
        • Wand M
        The influence of peripheral iridotomy on the intraocular pressure course in patients with pigmentary glaucoma.
        J Glaucoma. 2005; 14: 255-259
        • Glaucoma Laser Trial Group I
        Acute effects of argon laser trabeculoplasty on intraocular pressure. Glaucoma Laser Trial Research Group.
        Arch Ophthalmol. 1989; 107: 1135
        • Gandolfi SA
        • Vecchi M
        Effect of a YAG laser iridotomy on intraocular pressure in pigment dispersion syndrome.
        Ophthalmology. 1996; 103: 1693-1695
        • Ritch R
        Exfoliation syndrome and occludable angles.
        Trans Am Ophthalmol Soc. 1994; 92: 845-944
        • Konstas AG
        • Stewart WC
        • Stroman GA
        • Sine CS
        Clinical presentation and initial treatment patterns in patients with exfoliation glaucoma versus primary open-angle glaucoma.
        Ophthalmic Surg Lasers. 1997; 28: 111-117
        • Ritch R
        • Schlötzer-Schrehardt U
        • Konstas AG
        Why is glaucoma associated with exfoliation syndrome?.
        Prog Retin Eye Res. 2003; 22: 253-275
        • Schlotzer-Schrehardt UM
        • Koca MR
        • Naumann GO
        • Volkhlotz H
        Pseudoexfoliation syndrome. Ocular manifestation of a systemic disorder?.
        Arch Ophthalmol. 1992; 110: 1752-1756
        • Conway RM
        • Schlötzer-Schrehardt U
        • Küchle M
        • Naumann GO
        Pseudoexfoliation syndrome: pathological manifestations of relevance to intraocular surgery.
        Clin Experiment Ophthalmol. 2004; 32: 199-210
        • Konstas AG
        • Tsironi S
        • Ritch R
        Current concepts in the pathogenesis and management of exfoliation syndrome and exfoliative glaucoma.
        Compr Ophthalmol Update. 2006; 7: 131-141
        • Layden WE
        • Shaffer RN
        Pseudoexfoliation syndrome.
        Am J Ophthalmol. 1974; 78: 835
        • Naumann GO
        • Schlotzer-Schrehardt Yu
        • Kuchle M
        Pseudo-exfoliation syndrome for the comprehensive ophthalmologist. Intraocular and systemic manifestations.
        Ophthalmology. 1998; 105: 951-968
        • Shuba L
        • Nicolela MT
        • Rafuse PE
        Correlation of capsular pseudoexfoliation material and iridocorneal angle pigment with the severity of pseudoexfoliation glaucoma.
        J Glaucoma. 2007; 16: 94-97
        • Repo LP
        • Suhonen MT
        • Teräsvirta ME
        • Koivisto KJ
        Color Doppler imaging of the ophthalmic artery blood flow spectra of patients who have had a transient ischemic attack. Correlations with generalized iris transluminance and pseudoexfoliation syndrome.
        Ophthalmology. 1995; 102: 1199-1205
        • Mitchell P
        • Wang JJ
        • Smith W
        Association of pseudoexfoliation syndrome with increased vascular risk.
        Am J Ophthalmol. 1997; 124: 685-687
        • Citirik M
        • Acaroglu G
        • Batman C
        • Yildiran L
        • Zilelioglu O
        A possible link between the pseudoexfoliation syndrome and coronary artery disease.
        Eye. 2007; 21: 11-15
        • Ritland JS
        • Egge K
        • Lydersen S
        • et al.
        Exfoliative glaucoma and primary open-angle glaucoma: associations with death causes and comorbidity.
        Acta Ophthalmol Scand. 2004; 82: 401-404
        • Thorleifsson G
        • Magnusson KP
        • Sulem P
        • et al.
        Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma.
        Science. 2007; 317: 1397-1400
        • Liu X
        • Zhao Y
        • Gao J
        • Pawlyk B
        • Starcher B
        • Spencer JA
        • Yan-agisawa H
        • Zuo J
        • Li T
        Elastic fiber homeostasis requires lysyl oxidase-like 1 protein.
        Nat Genet. 2004; 36: 178-182
        • Konstas AG
        • Tsatsos I
        • Kardasopoulos A
        • Bufidis T
        • Maskaleris G
        Preoperative features of patients with exfoliation glaucoma and primary open-angle glaucoma. The AHEPA study.
        Acta Ophthalmol Scand. 1998; 76: 208-212
        • Konstas AG
        • Mylopoulos N
        • Karabatsas CH
        • et al.
        Diurnal intraocular pressure reduction with latanoprost 0.005% compared to timolol maleate 0.5% as monotherapy in subjects with exfoliation glaucoma.
        Eye. 2004; 18: 893-899
        • Konstas AG
        • Hollo G
        • Astakhov YS
        • et al.
        Factors associated with long-term progression or stability in exfoliation glaucoma.
        Arch Ophthalmol. 2004; 122: 29-33
        • Congdon NG
        • Quigley HA
        • Hung PT
        • et al.
        Screening techniques for angle closure glaucoma in rural Taiwan.
        Acta Ophthalmol Scand. 1996; 74: 113-119
        • Foster PJ
        • Baasanhu J
        • Alsbirk PH
        • et al.
        Glaucoma in Mongolia. A population based survey in Hovsgol province, northern Mongolia.
        Arch Ophthalmol. 1996; 114: 1235-1241
        • Sim DH
        • Goh LG
        • Ho T
        Glaucoma pattern amongst the elderly Chinese in Singapore.
        Ann Acad Med Singapore. 1998; 27: 819-823
        • Dandona L
        • Dandona R
        • Mandal P
        • et al.
        Angle closure glaucoma in an urban population in southern India.
        Ophthalmology. 2000; 107: 1710-1716
        • Vijaya L
        • George R
        • Arvind H
        • et al.
        Prevalence of angle closure disease in a rural southern Indian Population.
        Arch Ophthalmol. 2006; 124: 403-409
        • Casson RJ
        • Newland HS
        • Muecke J
        • et al.
        Goniscopy findings and prevalence of occludable angles in a Burmese population: the Meiktila Eye Study.
        Br J Ophthalmol. 2007; 91: 856-859
        • Aung T
        • Nolan WP
        • Machin D
        • et al.
        Anterior chamber depth and the risk of primary angle closure in 2 East Indian populations.
        Arch Ophthalmol. 2005; 123: 527-532
        • Foster PJ
        • Oen FTS
        • Machin D
        • et al.
        The prevalence of glaucoma in Chinese residents of Singapore.
        Arch Ophthalmol. 2000; 118: 1105-1111
        • Seah SKL
        • Foster PJ
        • Chew PTK
        • et al.
        Indidence of acute primary angle closure glaucoma in Singapore.
        Arch Ophthalmol. 1997; 115: 1436-1440
        • Arkell SM
        • Lightman DA
        • Sommer A
        • et al.
        The prevalence of glaucoma among Eskimos of northwest Alaska.
        Arch Ophthal-mol. 1987; 105: 482-485
        • Bourne RR
        • Sorensen KE
        • Klauber A
        • et al.
        Glaucoma in East Greenlandic Inuit-a population survey in Ittoqqortoormit.
        Acta Ophthalmol Scand. 2001; 79: 462-467
        • Van Rens GH
        • Arkell SM
        • Charlton W
        • Doesburg W
        Primary angle closure glaucoma among Alaskan Eskimos.
        Doc Ophthalmol. 1988; 70: 265-276
        • Lowe RF
        Aetiology of the anatomical basis for primary angle-closure glaucoma. Biometrical comparisons between normal eyes and eyes with primary angle-closure glaucoma.
        Br J Ophthalmol. 1970; 54: 1619
        • Spaeth GL
        Gonioscopy: uses old and new-the inheritance of occludable angles.
        Ophthalmology. 1978; 85: 222-232
        • Markowitz SN
        • Morin JD
        Angle-closure glaucoma relation between lens thickness, anterior chamber depth and age.
        Can J Ophthalmol. 1984; 19: 300-302
        • Amerasinghe N
        • Aung T
        Angle-closure: risk factors, diagnosis and treatment.
        Prog Brain Res. 2008; 173: 31-35
        • Drance SM
        Angle closure glaucoma among Canadian Eskimos.
        Can J Ophthalmol. 1973; 8: 252-254
        • Van Herick W
        • Shaffer RN
        • Schwartz A
        Estimation of width of angle of anterior chamber. Incidence and significance of the narrow angle.
        Am J Ophthalmol. 1969; 68: 626-629
        • Lavanya R
        • Wong TY
        • Friedman DS
        • Aung HT
        • Alfred T
        • Gao H
        • Seah SK
        • et al.
        Determinants of angle closure in older singaporeans.
        Arch Ophthalmol. 2008; 126: 686-691
        • Anderson DR
        Corneal indentation to relieve acute angle-closure glaucoma.
        Am J Ophthalmol. 1979; 88: 1091-1093
        • Lai JSM
        • Tham CCY
        • Chua JKH
        • et al.
        Laser peripheral irido-plasty as initial treatment of acute attack of primary angle closure: A long term follow up study.
        J Glaucoma. 2002; 11: 484-487
        • Lam DSC
        • Lai JSM
        • Tham CCY
        • et al.
        Argon laser peripheral iridoplasty versus conventional systemic medical therapy in treatment of acute primary angle closure glaucoma.
        Ophthalmology. 2002; 109: 1591-1596
        • Lam DSC
        • Chua JKH
        • Tham CCT
        • et al.
        Efficacy and safety of immediate anterior chamber paracentesis in the treatment of acute primary angle closure glaucoma.
        Ophthalmology. 2002; 109: 64-70
        • Greve EL
        Primary angle closure glaucoma: extracapsular extraction or filtering procedure?.
        Int Ophthalmol. 1988; 12: 157-162
        • Schwartz GF
        • Steinmann WC
        • Spaeth GL
        • Wilson RP
        Surgical and medical management of patients with narrow anterior chamber angles: comparative results.
        Ophthalmic Surg. 1992; 23: 108-112

      291. Ang LP, Aung T, Chew PT. Acute primary angle closure in an Asian population. Long term outcome of the fellow eye after prophylactic laser peripheral iridotomy. Ophthalmology 200;107:2092–6.

        • Friedman DS
        • Chew PTK
        • Gazzard G
        • et al.
        Long term outcomes in fellow eyes after acute primary angle closure in the contralateral eye.
        Ophthalmology. 2006; 113: 1087-1091
        • Saw SM
        • Gazzard DS
        • Friedman
        Interventions for angle closure glaucoma. An evidence based update.
        Ophthalmology. 2003; 110: 1869-1879
        • Iliev ME
        • Gerber S
        Long-term Outcome of trans-scleral laser cyclophotocoagulation in refractory glaucoma.
        Br J Ophthalmol. 2007; 91: 1631-1635
        • Chandler PA
        • Simmons RS
        • Grant WM
        Malignant glaucoma. Medical and surgical treatment.
        Am J Ophthalmol. 1968; 66: 2495-2502
        • Epstein DL
        • Steinert RF
        • Puliafito CA
        Neodymium-YAG laser therapy to the anterior hyaloid in aphakic malignant (ciliovitreal block) glaucoma.
        Am J Ophthalmol. 1984; 98: 137-143
        • Miglior S
        • Zeyen T
        • Pfeiffer N
        • Cunha-Vaz J
        • Torri V
        • Adamsons I
        • European Glaucoma Prevention Study Group
        The European glaucoma prevention study design and baseline description of the participants.
        Ophthalmology. 2002; 109: 1612-1621
        • Graham SL
        • Drance SM
        • Chauhan BC
        • et al.
        Comparison of psychophysical and electrophysiological testing in glaucoma.
        Invest Ophthalmol Vis Sci. 1996; 37: 2651-2662
        • Chauhan BC
        • Garway-Heath DF
        • Goni FJ
        • et al.
        Practical recommendations for measuring rates of visual field change in glaucoma.
        Br J Ophthalmol. 2008; 92: 569-573
        • AGIS Investigators
        • Advanced Glaucoma Intervention Study (AGIS)
        1. Study design and methods and baseline characteristics of study patients.
        Control Clin Trials. 1994; 15: 299-325
        • Musch DC
        • Lichter PR
        • Guire KE
        • Standardi CL
        The Collaborative Initial Glaucoma Treatment Study: study design, methods, and baseline characteristics of enrolled patients.
        Ophthalmology. 1999; 106: 653-662
        • Heijl A
        • Leske MC
        • Bengtsson B
        • Bengtsson B
        • Hussein M
        • Early Manifest Glaucoma Trial Group
        Measuring visual field progression in the Early Manifest Glaucoma Trial.
        Acta Ophthalmol Scand. 2003; 81: 286-293
        • Drance SM
        Disc hemorrhages in the glaucomas.
        Surv Ophthal-mol. 1989; 33: 331-337
        • Miglior S
        • Zeyen T
        • Pfeiffer N
        • Cunha-Vaz J
        • Torri V
        • Adamsons I
        • European Glaucoma Prevention Study Group
        The European glaucoma prevention study design and baseline description of the participants.
        Ophthalmology. 2002; 109: 1612-1621
        • AGIS Investigators
        • The Advanced Glaucoma Intervention Study (AGIS)
        12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma.
        Am J Ophthalmol. 2002; 134: 499-512
        • Caprioli J
        • Coleman AL
        Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressure in the advanced glaucoma intervention study.
        Ophthalmology. 2008; 115: 1123-1129
        • Noe G
        • Ferraro J
        • Lamoureux E
        • Rait J
        • Keeffe JE
        Associations between glaucomatous visual field loss and participation in activities of daily living.
        Clin Experiment Ophthalmol. 2003; 31: 482-486
        • Altangerel U
        • Spaeth GL
        • Rhee DJ
        Visual function, disability, and psychological impact of glaucoma.
        Curr Opin Ophthalmol. 2003; 14: 100-105
        • Janz NK
        • Wren PA
        • Lichter PR
        • Musch DC
        • Gillespie BW
        • Guire KE
        Quality of life in newly diagnosed glaucoma patients: The Collaborative Initial Glaucoma Treatment Study.
        Ophthalmology. 2001; 108: 887-897
        • Haymes SA
        • Leblanc RP
        • Nicolela MT
        • Chiasson LA
        • Chauhan BC
        Risk of falls and motor vehicle collisions in glaucoma.
        Invest Ophthalmol Vis Sci. 2007; 48: 1149-1155
        • Sherwood MB
        • Garcia-Siekavizza A
        • Meltzer MI
        • Hebert A
        • Burns AF
        • McGorray S
        Glaucoma's impact on quality of life and its relation to clinical indicators. A pilot study.
        Ophthalmology. 1998; 105: 561-566
        • Nelson P
        • Aspinall P
        • Papasouliotis O
        • Worton B
        • O’Brien C
        Quality of life in glaucoma and its relationship with visual function.
        Glaucoma. 2003; 12: 139-150
        • Kobelt G
        • Jonsson B
        • Bergström A
        • Chen E
        • Lindén C
        • Alm A
        Cost-effectiveness analysis in glaucoma: what drives utility? Results from a pilot study in Sweden.
        Acta Ophthalmol Scand. 2006; 84: 363-371
        • Parrish 2nd, RK
        • Gedde SJ
        • Scott IU
        • Feuer WJ
        • Schiffman JC
        • Mangione CM
        • Montenegro-Piniella A
        Visual function and quality of life among patients with glaucoma.
        Arch Ophthalmol. 1997; 115: 1447-1455
        • Hyman LG
        • Komaroff E
        • Heijl A
        • Bengtsson B
        • Leske MC
        • Early Manifest Glaucoma Trial Group
        Treatment and vision-related quality of life in the early manifest glaucoma trial.
        Ophthalmology. 2005; 112: 505-513
        • Gupta V
        • Srinivasan G
        • Mei SS
        • Gazzard G
        • Sihota R
        • Kapoor KS
        Utility values among glaucoma patients: an impact on the quality of life.
        Br J Ophthalmol. 2005; 89: 1241-1244
        • Blondeau P
        • Esper P
        • Mazerolle E
        An information session for glaucoma patients.
        Can J Ophthalmol. 2007; 42: 816-820
        • Asrani S
        • Zeiner R
        • Wilensky J
        • Gieser D
        • Vitale S
        • Lindenmuth K
        Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma.
        J Glaucoma. 2000; 9: 134-142
        • Stewart WC
        • Feldman R
        • Mychaskiw MA
        Ocular blood flow in glaucoma: the need for further clinical evidence and patient outcomes research.
        Br J Ophthalmol. 2007; 91: 1263-1264
        • Weinreb RN
        Glaucoma neuroprotection: What is it? Why is it needed?.
        Can J Ophthalmol. 2007; 42: 396-398
        • Borras T
        • Brandt CR
        • Nickells R
        • Ritch R
        Gene therapy for glaucoma: treating a multifaceted, chronic disease.
        Invest Ophthalmol Vis Sci. 2002; 43: 2513-2518
        • Japan Glaucoma Society
        The Japan Glaucoma Society Guidelines for Glaucoma. Japan Glaucoma Society, Tokyo2002 ([English translation, April 2004] Available at:)
        http://www.ryo-kunaisho.jp/english/Guidelines_for_Glaucoma.pdf
        (Accessed July 8, 2008)
        • American Academy of Ophthalmology
        Primary Open-Angle Glaucoma. Preferred Practice Pattern. American Academy of Ophthalmology, San Francisco, CA2005 (Available at:)
        http://one.aao.org/asset.axd?id=2e86ca2e-9db0-43c9-b605-c004a82b6ea5
        (Accessed July 8, 2008)
        • Hodapp E
        • Parrish RP
        • Anderson D
        Clinical Decisions in Glaucoma. CV Mosby Company, St. Louis, Mo.1993: 65
        • Miglior S
        • Zeyen T
        • Pfeiffer N
        • Cunha-Vaz J
        • Torri V
        • Adamsons I
        • European Glaucoma Prevention Study (EGPS) Group
        Results of the European Glaucoma Prevention Study.
        Ophthalmology. 2005; 112: 366-375
        • Feiner L
        • Piltz-Seymour JR
        • Collaborative Initial Glaucoma Treatment Study
        Collaborative Initial Glaucoma Treatment Study: a summary of results to date.
        Curr Opin Ophthalmol. 2003; 14: 106-111
        • Odberg T
        Visual field prognosis in advanced glaucoma.
        Acta Ophthalmol. 1987; 65: 27-29
        • Lachaine J
        • Hodge WG
        • Steffensen I
        • Murray C
        • Barnes D
        • Foerster V
        • et al.
        Prostaglandin analogues for ophthalmic use: a cost-effectiveness analysis.
        Can J Ophthalmol. 2008; 43: 33-41
        • Vass C
        • Hirn C
        • Sycha T
        • Findl O
        • Sacu S
        • Bauer P
        • Schmetterer L
        Medical interventions for primary open angle glaucoma and ocular hypertension.
        Cochrane Database Syst Rev. 2007; 4: CD003167
        • Zhang WY
        • Po AL
        • Dua HS
        • Azuara-Blanco A
        Meta-analysis of randomised controlled trials comparing latanoprost with timolol in the treatment of patients with open angle glaucoma or ocular hypertension.
        Br J Ophthalmol. 2001; 85: 983-990
        • Fechtner RD
        • Realini T
        Fixed combinations of topical glaucoma medications.
        Curr Opin Ophthalmol. 2004; 15: 132-135
        • Realini T
        • Fechtner RD
        • Atreides SP
        • Gollance S
        The uniocular drug trial and second-eye response to glaucoma medications.
        Ophthalmology. 2004; 111: 421-426
        • Sit AJ
        • Liu JH
        • Weinreb RN
        Asymmetry of right versus left intraocular pressures over 24 hours in glaucoma patients.
        Ophthalmology. 2006; 113: 425-430
        • Quigley HA
        • Friedman DS
        • Hahn SR
        Evaluation of practice patterns for the care of open-angle glaucoma compared with claims data: the Glaucoma Adherence and Persistency Study.
        Ophthalmology. 2007; 114: 1599-1606
        • Olthoff CM
        • Schouten JS
        • van de Borne BW
        • Webers CA
        Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review.
        Ophthalmology. 2005; 112: 953-961
        • Zhou Z
        • Althin R
        • Sforzolini BS
        • Dhawan R
        Persistency and treatment failure in newly diagnosed open angle glaucoma patients in the United Kingdom.
        Br J Ophthalmol. 2004; 88: 1391-1394
        • Sleath B
        • Robin AL
        • Covert D
        • Byrd JE
        • Tudor G
        • Svarstad B
        Patient-reported behavior and problems in using glaucoma medications.
        Ophthalmology. 2006; 113: 431-436
        • Patel SC
        • Spaeth GL
        Compliance in patients prescribed eye drops for glaucoma.
        Ophthalmic Surg. 1995; 26: 233-236
        • Englert JA
        • Cox TA
        • Allingham RR
        • Shields MB
        Argon vs diode laser trabeculoplasty.
        Am J Ophthalmol. 1997; 124: 627-631
        • Glaucoma Laser Trial Research Group
        Glaucoma Laser Trial (GLT) and glaucoma laser trial follow-up Study: 7. Results.
        Am J Ophthalmol. 1995; 120: 718-731
        • Spaeth GL
        • Baez KA
        Argon laser trabeculoplasty controls one third of cases of progressive, uncontrolled, open angle glaucoma for 5 years.
        Arch Ophthalmol. 1992; 110: 491-494
        • Schwartz AL
        • Love DC
        • Schwartz MA
        Long-term follow-up of argon laser trabeculoplasty for uncontrolled open-angle glaucoma.
        Arch Ophthalmol. 1985; 103: 1482-1484
        • Krupin T
        • Patkin R
        • Kurata FK
        • Bishop KI
        • Keates EU
        • Kozart DM
        • et al.
        Argon laser trabeculoplasty in black and white patients with primary open-angle glaucoma.
        Ophthalmology. 1986; 93: 811-816
        • Shingleton BJ
        • Richter CU
        • Dharma SK
        • et al.
        Long-term efficacy of argon laser trabeculoplasty. A 10-year follow-up study.
        Ophthalmology. 1993; 100: 1324-1329
        • Damji KF
        • Bovell AM
        • Hodge WG
        • Rock W
        • Shah K
        • Buhrmann R
        • Pan YI
        Selective laser trabeculoplasty versus argon laser trabeculoplasty: results from a 1-year randomised clinical trial.
        Br J Ophthalmol. 2006; 90: 1490-1494
        • Nagar M
        • Ogunyomade A
        • O’Brart DP
        • Howes F
        • Marshall J
        A randomised, prospective study comparing selective laser trabeculoplasty with latanoprost for the control of intraocular pressure in ocular hypertension and open angle glaucoma.
        Br J Ophthalmol. 2005; 89: 1413-1417
        • Ren J
        • Shin DH
        • Chung HS
        • Birt CM
        • Glover BK
        • Juzych MS
        • et al.
        Efficacy of apraclonidine 1% versus pilocarpine 4% for prophylaxis of intraocular pressure spike after argon laser trabeculoplasty.
        Ophthalmology. 1999; 106: 1135-1139
        • Ma YR
        • Lee BH
        • Yang KJ
        • Park YG
        The efficacy of 0.2% brimonidine for preventing intraocular pressure rise following argon laser trabeculoplasty.
        Korean J Ophthalmol. 1999; 13: 78-84
        • Elsås T
        • Johnsen H
        • Brevik TA
        The immediate pressure response to primary laser trabeculoplasty—a comparison of one-and two-stage treatment.
        Acta Ophthalmol. 1989; 67: 664-668
        • Rachmiel R
        • Trope GE
        • Chipman ML
        • Gouws P
        • Buys YM
        Effect of medical therapy on glaucoma filtration surgery rates in Ontario.
        Arch Ophthalmol. 2006; 124: 1472-1477
        • AGIS Investigators
        Advanced Glaucoma Intervention Study (AGIS); 13. Comparison of treatment outcomes within race: 10-year results.
        Ophthalmology. 2004; 111: 651-664
        • Araujo SV
        • Spaeth GL
        • Roth SM
        • Starita RJ
        A ten-year follow-up on a prospective, randomized trial of postoperative corticosteroids after trabeculectomy.
        Ophthalmology. 1995; 102: 1753-1759
        • Fluorouracil Filtering Surgery Study Group
        Fluorouracil Filtering Surgery Study one-year follow-up.
        Am J Ophthalmol. 1989; 108: 625-635
        • Wormald R
        • Wilkins MR
        • Bunce C
        Postoperative 5-Fluorouracil for glaucoma surgery.
        Cochrane Database Syst Rev. 2001; 1: CD001132
        • Wilkins M
        • Indar A
        • Wormald R
        Intraoperative mitomycin C for glaucoma surgery.
        Cochrane Database Syst Rev. 2005; 4: CD002897
        • Costa VP
        • Wilson RP
        • Moster MR
        • et al.
        Hypotony maculopathy following the use of topical mitomycin C in glaucoma filtration surgery.
        Ophthalmic Surg. 1993; 24: 389-394
        • Zacharia PT
        • Deppermann SR
        • Schuman JS
        Ocular hypotony after trabeculectomy with mitomycin C.
        Am J Ophthalmol. 1993; 116: 314-326
        • Greenfield DS
        • Liebmann JM
        • Jee J
        • Ritch R
        Late-onset bleb leaks after glaucoma filtering surgery.
        Arch Ophthalmol. 1998; 116: 443-447
        • Soltau JB
        • Rothman RF
        • Budenz DL
        • et al.
        Risk factors for glaucoma filtering bleb infections.
        Arch Ophthalmol. 2000; 118: 338-342
        • Jampel HD
        • Quigley HA
        • Kerrigan-Baumrind LA
        • Meila BM
        • Friedman D
        • Barron Y
        • Glaucoma Surgical Outcomes Study Group
        Risk factors for late-onset infection following glaucoma filtration surgery.
        Arch Ophthalmol. 2001; 119: 1001-1008
        • Whiteside-Michel J
        • Liebmann JM
        • Ritch R
        Initial 5-fluorouracil trabeculectomy in young patients.
        Ophthalmology. 1992; 99: 7-13
        • Suñer IJ
        • Greenfield DS
        • Miller MP
        • Nicolela MT
        • Palmberg PF
        Hypotony maculopathy after filtering surgery with mitomycin C. Incidence and treatment.
        Ophthalmology. 1997; 104: 207-214
        • Yarangümeli A
        • Güreser S
        • Köz OG
        • Elhan AH
        • Kural G
        Viscocanalostomy versus trabeculectomy in patients with bilateral high-tension glaucoma.
        Int Ophthalmol. 2004; 25: 207-213
        • Yalvac IS
        • Sahin M
        • Eksioglu U
        • Midillioglu IK
        • Aslan BS
        • Duman S
        Primary viscocanalostomy versus trabeculectomy for primary open-angle glaucoma: three-year prospective randomized clinical trial.
        J Cataract Refract Surg. 2004; 30: 2050-2057
        • Lüke C
        • Dietlein TS
        • Jacobi PC
        • Konen W
        • Krieglstein GK
        A prospective randomized trial of viscocanalostomy versus trabeculectomy in open-angle glaucoma: a 1-year follow-up study.
        J Glaucoma. 2002; 11: 294-299
        • Kobayashi H
        • Kobayashi K
        • Okinami S
        A comparison of the intraocular pressure-lowering effect and safety of viscocanalostomy and trabeculectomy with mitomycin C in bilateral open-angle glaucoma.
        Graefes Arch Clin Exp Ophthalmol. 2003; 241: 359-366
        • Carassa RG
        • Bettin P
        • Fiori M
        • Brancato R
        Viscocanalostomy versus trabeculectomy in white adults affected by open-angle glaucoma: a 2-year randomized, controlled trial.
        Ophthalmology. 2003; 110: 882-887
        • El Sayyad F
        • Helal M
        • El-Kholify H
        • Khalil M
        • El-Maghraby A
        Nonpenetrating deep sclerectomy versus trabeculectomy in bilateral primary open-angle glaucoma.
        Ophthalmology. 2000; 107: 1671-1674
        • Jonescu-Cuypers C
        • Jacobi P
        • Konen W
        • Krieglstein G
        Primary viscocanalostomy versus trabeculectomy in white patients with open-angle glaucoma: A randomized clinical trial.
        Ophthalmology. 2001; 108: 254-258
        • Netland PA
        • Ophthalmic Technology Assessment Committee Glaucoma Panel
        American Academy of Ophthalmology. Nonpenetrating glaucoma surgery.
        Ophthalmology. 2001; 108: 416-421
        • Hong CH
        • Arosemena A
        • Zurakowski D
        • Ayyala RS
        Glaucoma drainage devices: a systematic literature review and current controversies.
        Surv Ophthalmol. 2005; 50: 48-60
        • Minckler DS
        • Vedula SS
        • Li TJ
        • Mathew MC
        • Ayyala RS
        • Francis BA
        Aqueous shunts for glaucoma.
        Cochrane Database Syst Rev. 2006; 2: CD004918
        • Gedde SG
        • Schiffman JC
        • Feuer WJ
        • Herndon LW
        • Brandt JD
        • Budenz DL
        Treatment outcomes in the tube versus trabeculectomy study after one year of follow-up.
        Am J Ophthalmol. 2007; 143: 9-22
        • Pastor SA
        • Singh K
        • Lee DA
        • et al.
        Cyclophotocoagulation: a report by the American Academy of Ophthalmology.
        Ophthalmology. 2001; 108: 2130-2138
        • AGIS Investigators
        The Advanced Glaucoma Intervention Study (AGIS): 8. Risk of cataract formation after trabeculectomy.
        Arch Ophthalmol. 2001; 119: 1771-1780
        • Lichter PR
        • Müsch DC
        • Gillespie BW
        • et al.
        • CIGTS Study Group
        Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery.
        Ophthalmology. 2001; 108: 1943-1953
        • Canadian Ophthalmological Society Cataract Surgery Clinical Practice Guideline Expert Committee
        Canadian Ophthalmo-logical Society evidence-based clinical practice guidelines for cataract surgery in the adult eye.
        Can J Ophthalmol. 2008; 43: S1-S34
        • Friedman DS
        • Jampel HD
        • Lubomski LH
        • Kempen JH
        • Quigley H
        • Congdon N
        • Levkovitch-Verbin H
        • Robinson KA
        • Bass EB
        Surgical strategies for coexisting glaucoma and cataract. An evidence-based update.
        Ophthalmology. 2002; 109: 1902-1915
        • Hayashi K
        • Hayashi H
        • Nakao F
        • Hayashi F
        Changes in anterior chamber angle width and depth after intraocular lens implantation in eyes with glaucoma.
        Ophthalmology. 2000; 107: 698-703
        • Shingleton BJ
        • Heltzer J
        • O’Donoghue MW
        Outcomes of phacoemulsification in patients with and without Pseudoexfoliation syndrome.
        J Cataract Refract Surg. 2003; 29: 1080-1086
        • Damji KF
        • Konstas AG
        • Liebmann JM
        • et al.
        Intraocular pressure following phacoemulsification in patients with and without exfoliation syndrome: a 2 year prospective study.
        Br J Ophthalmol. 2006; 90: 1014-1018
        • Willoughby CE
        • Wishart PK
        Lensectomy in the management of glaucoma in spherophakia.
        J Cataract Refract Surg. 2002; 28: 1061-1064
        • Heltzer JM
        Coexisting glaucoma and cataract [comment].
        Ophthalmology. 2004; 111: 408-409
        • Hayashi K
        • Hayashi H
        • Nakao F
        • Hayashi F
        Effect of cataract surgery on intraocular pressure control in glaucoma patients.
        J Cataract Refract Surg. 2001; 27: 1779-1786
        • Crichton AC
        • Kirker AW
        Intraocular pressure and medication control after clear corneal phacoemulsification and AcrySof posterior chamber intraocular lens implantation in patients with filtering blebs.
        J Glaucoma. 2001; 10: 38-64
        • Casson R
        • Rahman R
        • Salmon JF
        Phacoemulsification with intraocular lens implantation after trabeculectomy.
        J Glaucoma. 2002; 11: 429-433
        • Mandai AK
        • Chelerkar V
        • Jain SS
        • et al.
        Outcome of cataract extraction and posterior chamber intraocular lens implantation following glaucoma filtration surgery.
        Eye. 2005; 19: 1000-1008
        • Rossetti L
        • Bucci L
        • Miglior S
        • Orzalesi N
        Temporal corneal phacoemulsification combined with separate-incision superior trabeculectomy vs standard phacotrabeculectomy. A comparative study.
        Acta Ophthalmol Scand Suppl. 1997; 224: 39
        • Peräsalo R
        • Flink T
        • Lehtosalo J
        • Ralli R
        • Sulonen J
        Surgical outcome of phaco-emulsification combined with trabeculectomy in 243 eyes.
        Acta Ophthalmol Scand. 1997; 75: 581-583
        • Wyse T
        • Meyer M
        • Ruderman JM
        • Krupin T
        • Talluto D
        • Hernandez R
        • Rosenberg LF
        Combined trabeculectomy and phacoemulsification: A one-site vs a two-site approach.
        Am J Ophthalmol. 1998; 125: 334-339
        • Bellucci R
        • Luraschi M
        Trabeculectomy and phacoemulsification: one-way and two-way approach compared after one year.
        Acta Ophthalmol Scand Suppl. 1998; 227: 50-51
        • Borggrefe J
        • Lieb W
        • Grehn F
        A prospective randomized comparison of two techniques of combined cataract-glaucoma surgery.
        Graefes Arch Clin Exp Ophthalmol. 1999; 237: 887-892
        • El Sayyad F
        • Helal M
        • El-Maghraby A
        • Khalil M
        • El-Hamzawey H
        One-site versus 2-site phacotrabeculectomy: A randomized study.
        J Cataract Refract Surg. 1999; 25: 77-82
        • Shingleton BJ
        • Price RS
        • O’Donoghue MW
        • Goyal S
        Comparison of 1-site versus 2-site phacotrabeculectomy.
        J Cataract Refract Surg. 2006; 32: 799-802

      395. Cotran PR, Roh S, McGwin G. Randomized comparison of 1-site and 2-site phacotrabeculectomy with 3-year follow-up. Ophthalmology; 115:44754.

        • Buys YM
        • Chipman ML
        • Zack B
        • Rootman DS
        • Slomovick AR
        • Trope GE
        Prospective randomized comparison of one- versus two-site phacotrabeculectomy: two-year results.
        Ophthalmology. 2008; 115: 1130-1133
        • Jampel HD
        • Friedman DS
        • Lubomski LH
        • et al.
        Effect of technique on intraocular pressure after combined cataract and glaucoma surgery. An evidence-based review.
        Ophthalmology. 2002; 109: 2215-2224
        • Casson RJ
        • Salmon JF
        Combined surgery in the treatment of patients with cataract and primary open-angle glaucoma.
        J Cataract Refract Surg. 2001; 27: 1854-1863
        • Hopkins JJ
        • Apel A
        • Trope GE
        • Rootman DS
        Early intraocular pressure after phacoemulsification combined with trabeculectomy.
        Ophthalmic Surg Lasers. 1998; 29: 273-279
        • Lemon LC
        • Shin DH
        • Kim C
        • Bendel RE
        • Hughes BA
        • Juzych MS
        Limbus-based vs fornix-based conjunctival flap in combined glaucoma and cataract surgery with adjunctive mitomycin C.
        Am J Ophthalmol. 1998; 125: 340-345
        • Shingleton BJ
        • Chaudhry IM
        • O’Donoghue MW
        • Baylus SL
        • King RJ
        • Chaudry MB
        Phacotrabeculectomy: limbus-based versus fornix-based conjuinctival flaps in fellow eyes.
        Ophthalmology. 1999; 106: 1152-1155
        • Kozobolis VP
        • Siganos CS
        • Christodoulakis EV
        • Lazarow NP
        • Koutentaki MG
        • Pallikaris IG
        Two-site phacotrabeculectomy with intraoperative mitomycin C: fornix- versus limbus-based conjunctival opening in fellow eyes.
        J Cataract Refract Surg. 2002; 28: 1758-1762

      Article info

      Publication history

      Accepted: March 16, 2009
      Received in revised form: February 15, 2009
      Received: December 1, 2008

      Identification

      DOI: https://doi.org/10.1016/S0008-4182(09)80037-9

      Copyright

      © 2009 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX